Dr Lal Pathlabs' Q2 FY 2025-26 Quarterly Results
- 01 Nov 2025
Result Summary
- Dr Lal Pathlabs Ltd reported a 8.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 10.7%.
- Its expenses for the quarter were up by 6.8% QoQ and 10.6% YoY.
- The net profit increased 13.6% QoQ and increased 16.4% YoY.
- The earnings per share (EPS) of Dr Lal Pathlabs Ltd stood at 18.01 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
| (₹ crores) | Q2FY26 | Q1FY26 | Q2FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 755.40 | 697.90 | 682.10 | 8.2% | 10.7% |
Total Expenses | 551.80 | 516.80 | 499.00 | 6.8% | 10.6% |
Profit Before Tax | 203.60 | 181.10 | 183.10 | 12.4% | 11.2% |
Tax | 51.40 | 47.10 | 52.30 | 9.1% | -1.7% |
Profit After Tax | 152.20 | 134.00 | 130.80 | 13.6% | 16.4% |
Earnings Per Share | 18.01 | 15.85 | 15.48 | 13.6% | 16.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Dr Lal Pathlabs Ltd is a prominent diagnostic and related healthcare service provider in India. The company is primarily involved in the business of providing laboratory testing and diagnostic services. It operates in the healthcare sector, which is a crucial part of the country's infrastructure, offering a wide range of tests across various medical disciplines. Dr Lal Pathlabs is known for its extensive network of laboratories and collection centers across the nation, ensuring accessibility and reliability in diagnostic services.
Revenue
During the second quarter of fiscal year 2026 (Q2FY26), Dr Lal Pathlabs Ltd reported a total income of ₹755.40 crores, which reflects an 8.2% increase from the ₹697.90 crores recorded in the previous quarter (Q1FY26) and a 10.7% rise compared to the ₹682.10 crores reported in the same quarter of the previous year (Q2FY25). This growth in revenue indicates a consistent upward trajectory in the company's income over both the quarterly and yearly periods.
Profitability
In Q2FY26, the company's profit before tax amounted to ₹203.60 crores, experiencing a 12.4% increase from ₹181.10 crores in Q1FY26 and an 11.2% rise from ₹183.10 crores in Q2FY25. The profit after tax for the same period was ₹152.20 crores, showing a 13.6% growth from the previous quarter's ₹134.00 crores, and a 16.4% increase from ₹130.80 crores in the same quarter last year. The tax expense for Q2FY26 was ₹51.40 crores, which is 9.1% higher than Q1FY26 but slightly lower by 1.7% compared to Q2FY25. Earnings per share (EPS) for Q2FY26 stood at ₹18.01, marking a 13.6% increase from Q1FY26's ₹15.85 and a 16.3% rise from ₹15.48 in Q2FY25.
Operating Metrics
Dr Lal Pathlabs Ltd's total expenses for Q2FY26 were ₹551.80 crores, which represents a 6.8% increase from ₹516.80 crores in Q1FY26 and a 10.6% escalation from ₹499.00 crores in Q2FY25. The increase in expenses aligns with the growth in total income, maintaining a balance in operational efficiency. The company's operations during this quarter reflect both a quarter-over-quarter and year-over-year improvement in its financial performance metrics, indicating sustained growth in its core business activities.
FAQs
When was Dr Lal Pathlabs Ltd Q2 FY 2025-26 result announced?
Dr Lal Pathlabs Ltd announced its Q2 FY 2025-26 results on 1 November, 2025.
What are Dr Lal Pathlabs Ltd quarterly results?
Dr Lal Pathlabs Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
What were the key highlights of Dr Lal Pathlabs Ltd Q2 FY 2025-26 results?
Key highlights of Dr Lal Pathlabs Ltd Q2 FY 2025-26 results include:
- Revenue: ₹755.40 crore
- Net Profit: ₹152.20 crore
- EBITDA: ₹248.90 crore
- Year-over-Year Growth: 10.7%
- Quarter-over-Quarter Growth: 8.2%
How did Dr Lal Pathlabs Ltd net profit perform in this quarter?
Dr Lal Pathlabs Ltd reported a net profit of ₹152.20 crore in Q2 FY 2025-26, reflecting a 16.4% year-over-year growth.
What was Dr Lal Pathlabs Ltd revenue in Q2 FY 2025-26?
Dr Lal Pathlabs Ltd posted a revenue of ₹755.40 crore in Q2 FY 2025-26.